Today’s Research Reports on Trending Tickers: ACADIA Pharmaceuticals and Immunomedics

NEW YORK, NY / ACCESSWIRE / March 27, 2018 / U.S markets rallied Monday, after posting their worst weekly loss in two years last week, on easing tensions between the U.S. and China. The Dow Jones Industrial Average gained 2.84 percent to close at 24,202.60, while the S&P 500 Index jumped 2.72 percent to close at 2,658.55. The Nasdaq Composite Index spiked 3.26 percent to close at 7,220.54. The Wall Street Journal has reported that officials from China and the U.S. have begun negotiations “to improve U.S. access to mainland Chinese markets.”

“Big positive moves in stocks tend to come after biggest down days, and today’s action looks like a technical bounce, just because markets were so weak for days,” said Mike Antonelli, equity sales trader at Robert W. Baird & Co., according to MarketWatch.

RDI Initiates Coverage on:

ACADIA Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=ACAD

Immunomedics, Inc.
https://rdinvesting.com/news/?ticker=IMMU

ACADIA Pharmaceuticals’ stock moved 4.30% higher Monday, to close the day at $23.54. The stock recorded a trading volume of 1,616,780 shares, which was below its three months average volume of 2,029,734 shares. In the last year, ACADIA Pharmaceuticals’ shares have traded in a range of 22.35 – 41.20. The stock is currently trading 42.86% below its 52 week high. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $27.17 is below its 200-day moving average of $30.97. Shares of ACADIA Pharmaceuticals have fallen roughly 27.19 percent in the past month and are down 21.82 percent year-to-date.

Access RDI’s ACADIA Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ACAD

On Monday, shares of Immunomedics recorded a trading volume of 2,438,698 shares, which was above the three months average volume of 2,382,375 shares. The stock ended the day 6.57% higher at 15.90. The share price has gained 218.00% from its 52-week low with a 52-week trading range of 5.00 – 18.93. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $16.33 is greater than its 200-day moving average of $13.77. Shares of Immunomedics have fallen roughly 8.04 percent in the past month and are down 1.61 percent year-to-date.

Access RDI’s Immunomedics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=IMMU

Our Actionable Research on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and Immunomedics, Inc. (NASDAQ:IMMU) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 494375